AptarGroup

Rising Global Wellness Trends Will Unlock Biologics And Smart Packaging

AnalystHighTarget

Not Invested

Consensus Narrative from 7 Analysts

Published

07 Sep 25

AnalystHighTarget's Fair Value

US$220.00

38.7% undervalued

10 Sep

US$134.85

-11.9%

-2.5%

-11.9%

-2.5%

Edit anytime before Sep 7 9:11 PM. Then post Updates to your followers.

Author's Valuation

US$220.0

38.7% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$220

38.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.93%

Packaging revenue growth rate

0.20%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.80%

Calculation

US$486.78m

Earnings '28

34.66x

PE Ratio '28

US$16.87b

Market Cap '28

US$16.87b

Market Cap '28

63.93m

No. shares '28

US$263.92

Share Price '28

US$263.92 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$216.79

Fair Value '25